D-1234-2014 Class I Terminated
FDA drug recall D-1234-2014 was initiated by Hospira, Inc. on Sep 16, 2013 and is designated Class I. Reason for recall: Presence of Particulate Matter: Oxidized stainless steel found in vial of 1% Lidocaine Hydrochloride Injection, USP. The recall status is terminated (terminated Nov 4, 2014). Affected quantity: 374,500 vials.
Recall Details
- Product Type
- Drugs
- Report Date
- Apr 23, 2014
- Initiation Date
- Sep 16, 2013
- Termination Date
- Nov 4, 2014
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 374,500 vials
Product Description
1% Lidocaine HCl Injection, USP, 10 mg/mL, NDC 0409-4276-01, Hospira, Inc., Lake Forest, IL 60045.
Reason for Recall
Presence of Particulate Matter: Oxidized stainless steel found in vial of 1% Lidocaine Hydrochloride Injection, USP.
Distribution Pattern
Nationwide
Code Information
Lot #25090DK; Exp 01/15
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1234-2014
- openFDA file date
- Oct 27, 2026
- Loaded by RegDataLab
- Oct 29, 2026